MELATONIN M/R 1mg and 5mg tablets (Slenyto®)
Clinical Indication
Insomnia for children aged 2-18 years with Autism Spectrum Disorder and or Smith-Magenis syndrome
Date of classification
August 2019
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .